Varian has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumours. The planned acquisition of the drug-loadable microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products, a press release reports, will enable Varian to extend its new [...]